Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The clinical focus of Nabila (Nora) N. Bennani, M.D., is on treating lymphomas, while her particular research focus is on T-cell lymphomas. Dr. Bennani's goal is to develop early-phase novel clinical trials with the aim of uncovering novel therapies and improving outcomes for patients. She serves as a principal investigator, co-principal investigator and co-investigator in several ongoing and in-development clinical trials. She is also among select faculty members that provide chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for relapsed lymphomas.
T-cell lymphoma is a rare type of lymphoma with worse outcomes than other lymphoma subtypes. Through the study of biology of T-cell lymphoma, Dr. Bennani's goal is to find effective, chemotherapy-free, novel treatment options that lead to improved outcomes in T-cell lymphoma.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.